欧洲牙科膜和骨移植替代品市场 – 行业趋势和 2030 年预测

欧洲牙科膜和骨移植替代品市场分析和规模

根据美国疾病控制与预防中心的报告，全球女性髋部骨折的发生率预计将上升 240%，男性将上升 310%。据估计，全球有 2 亿女性患有骨质疏松症。由于骨密度低，骨骼疾病在老年人中很常见。2016 年，65 岁及以上美国人的数量估计约为 4600 万，到 2060 年将上升至 9800 万。肌肉骨骼疾病发病率的增加和人口老龄化是牙科膜和骨移植替代品市场创新的某些因素。

Data Bridge Market Research 分析，牙科膜和骨移植替代品市场在 2022 年为 4.2396 亿美元，预计到 2030 年将达到 8.7627 亿美元，在 2023 年至 2030 年的预测期内复合年增长率为 9.5%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

欧洲牙科膜和骨移植替代品市场范围和细分      

Market Definition

Dental membranes and bone graft substitutes are used in dental bone regeneration procedures in patients suffering from periodontal diseases and oral cancer. Dental membranes are used in conjunction with dental bone grafts to promote cell proliferation during regeneration. A bone graft is an implantable material used to promote bone formation, bone healing, osseous reconstruction, and other procedures.

Europe Dental Membrane and Bone Graft Substitute Market Dynamics

Drivers

• Rising incidence of trauma and accident cases

Osteoarthritis is one of the most common articular diseases in people over the age of 65. According to the Centers for Disease Control and Prevention (CDC), an estimated 63 million Americans have arthritis, which is expected to rise to 78 million by 2040. Furthermore, according to World Population Prospects: The 2019 Revision Data, 1 in 11 people in 2019 were over the age of 65. This figure is expected to rise to one in every six people by 2050.

Furthermore, an increasing incidence of trauma and accident cases worldwide is a major factor likely to boost market demand. According to the National Safety Council, approximately 4.5 million people were severely injured in accidents in 2018. Thus, the above-mentioned factors, the dental membrane and bone graft substitute market is expected to witness significant growth over the forecast period.

• High incidence of periodontal disorders

The rising prevalence of oral health disorders such as periodontal disease and oral cancer is expected to drive the growth of the global dental membranes and bone graft substitutes market during the forecast period. For instance, the National Center for Biotechnology Information (NCBI) article Assessment of the Status of National Oral Health Policy in India, published in 2015, states that the prevalence of oral diseases is very high in India, with dental caries being the most common. It reports that the prevalence is 50.0%, 52.5%, 61.4%, 79.2%, and 84.7% in people aged 5, 12, 15, 35-44, and 65-74, respectively.

• Rising number of bone fracture cases

The increasing number of bone fracture cases and the effectiveness of external bone growth stimulators in healing fractures are driving up product demand. According to a study published in the Archives of Osteoporosis, 2020, fragility fractures accounted for 2.7 million in 2017 in the five largest European Union countries plus Sweden (EU6) and are expected to reach 3.3 million by 2030, a 23% increase from 2017. Furthermore, 14% of the Australian population has osteoporosis, according to a study published in the Orthopaedic Trauma Association International in 2020, and 60,000 hip fractures are expected to occur in Australia by 2050. This reflects the growing global fracture burden. As a result, there is an increasing demand for external bone growth stimulators, which will contribute to the growth of the industry.

• Increased product development

Manufacturers' increased product development and focus on meeting demand for efficient therapeutics are expected to drive market growth during the forecast period. For instance, according to the National Oral Health Survey of India, the prevalence of periodontal diseases in people aged 65 to 74 years was approximately 79.9%, while the incidence of oral cancer in India was approximately 12.6 per 100,000 people in 2016-2017.

Opportunities

• Rise in prevalence of orthopedic diseases

According to the Arthritis Foundation, degenerative joint disease disorders such as osteoarthritis will affect nearly 130 million people worldwide by 2050. The increased prevalence and burden of orthopaedic diseases have resulted in increased patient pool undergoing minimally invasive surgeries worldwide. As a result, dental membrane and bone graft substitutes are in high demand. The high prevalence of bone marrow transplants and bone cancers increases the demand for dental membrane and bone graft substitute.

Restraints/Challenges

• Limited medical reimbursement

Limited medical reimbursement for bone stimulation products and high treatment costs associated with BMP and PRP products will obstruct market growth, while side effects associated with BMP-based orthopaedic treatment will further challenge market growth during the forecast period.

This dental membrane and bone graft substitute market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the dental membrane and bone graft substitute market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Dental Membrane and Bone Graft Substitute Market

The COVID-19 had a negative impact on the dental membrane and bone graft substitute market. Companies are facing a setback lockdown, which has caused disruptions in supply chain activities around the world. The worldwide implementation of lockdown restrictions has resulted in a decrease in patient visits. However, the situation is projected to improve as governments around the world begin to ease guidelines for resuming business activities. Furthermore, the demand for dental membrane and bone graft substitute is expected to rise as elective surgeries and procedures resume in the near future.

Recent developments

• In October 2021, Nobel Biocare launched the GalvoSurge Dental Implant Cleaning System, which completely removes biofilm from bacteria-infected titanium implants. It removes biofilm from difficult-to-reach areas of any bacteria-infected titanium implant surface.
• In January 2021, Dentsply Sirona announced the acquisition of Datum Dental, Ltd. and its extensive portfolio of OSSIX biomaterials. Datum Dental, based in Israel, is well-known for its cutting-edge dental regeneration solutions, which include the clinically superior GLYMATRIX unique technology.

Europe Dental Membrane and Bone Graft Substitute Market Scope

The dental membrane and bone graft substitute market is segmented on the basis of product type, material, application and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Dental Membranes
• Resorbable
• Non-resorbable
• Dental Bone Grafts
• Autograft
• Allograft
• Demineralized bone matrix
• Xenograft
• Synthetic bone graft substitutes

 Material

• Hydrogel
• Collagen
• Human Cells Source
• Hydroxyapatite
• Tricalcium Phosphate
• Polytetrafluroethylene

 Application

• Ridge Augmentation
• Socket Preservation
• Periodontal Defect Regeneration
• Implant Bone Regeneration
• Sinus Lift
• Others

 End Use

• Hospitals
• Dental Clinics
• Ambulatory Surgical Centers

Europe Dental Membrane and Bone Graft Substitute Market Regional Analysis/Insights

The dental membrane and bone graft substitute market is analyzed and market size insights and trends are provided by country, product type, material, application and end-use as referenced above.

The countries covered in the dental membrane and bone graft substitute market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe

Germany dominates the European region for dental membrane and bone graft substitute because Germany is heavily investing in research and development to provide better patient care. Furthermore, the leading manufacturers in Germany are present, implying that it controls the largest share of the European market.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

牙科膜和骨移植替代品市场还为您提供每个国家/地区资本设备医疗保健支出增长、牙科膜和骨移植替代品市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对牙科膜和骨移植替代品市场的影响的详细市场分析。数据适用于 2011-2021 年的历史时期。

竞争格局和牙科膜和骨移植替代品市场份额分析

牙科膜和骨移植替代品市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对牙科膜和骨移植替代品市场的关注有关。

牙科膜和骨移植替代品市场的一些主要参与者包括：

• Zimmer Biomet（美国）
• Bioventus（美国）
• Synergy Orthopedics（美国）
• 伊藤株式会社（日本）
• 波士顿科学公司 (美国)
• BTL（加拿大）
• Cyber​​onics, Inc.（美国）
• DJO LLC（美国）
• 美敦力（爱尔兰）
• Nevro Corp（美国）
• NeuroMetrix, Inc（美国）
• 雅培（美国）
• Uroplasty Inc（美国）
• Cogentix Medical（美国）
• Aleva Neurotherapeutics（瑞士）
• NeuroPace Inc（美国）
• AxioBionics（美国）
• Beurer GmbH（德国）
• 欧姆龙医疗有限公司（日本）
• RS Medical（日本）
• 史赛克（美国）

研究方法：欧洲牙科膜和骨移植替代品市场

数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息，请请求分析师致电或下拉询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，涉及数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们很自豪能够为现有和新客户提供符合其目标的数据和分析。报告可以定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（Factbook）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

SKU-55358